Literature DB >> 33535645

Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells.

Megumu K Saito1.   

Abstract

Autoinflammatory diseases are a disease entity caused by the dysregulation of innate immune cells. Typical autoinflammatory diseases are monogenic disorders and often very rare. As a result, there is a relative lack of understanding of the pathogenesis, poor diagnosis and little available treatment. Induced pluripotent stem (iPS) cells are a new technology being applied to in vitro disease modeling. These models are especially useful for the analysis of rare and intractable diseases including autoinflammatory diseases. In this review, I will provide a general overview of iPS cell models for autoinflammatory diseases and a brief description of the results obtained from individual reports.

Entities:  

Keywords:  autoinflammatory diseases; genome editing; iPS cells; macrophages; somatic mosaicism

Year:  2021        PMID: 33535645      PMCID: PMC7912798          DOI: 10.3390/children8020094

Source DB:  PubMed          Journal:  Children (Basel)        ISSN: 2227-9067


  75 in total

1.  Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome.

Authors:  Kazuhiko Arima; Akira Kinoshita; Hiroyuki Mishima; Nobuo Kanazawa; Takeumi Kaneko; Tsunehiro Mizushima; Kunihiro Ichinose; Hideki Nakamura; Akira Tsujino; Atsushi Kawakami; Masahiro Matsunaka; Shimpei Kasagi; Seiji Kawano; Shunichi Kumagai; Koichiro Ohmura; Tsuneyo Mimori; Makito Hirano; Satoshi Ueno; Keiko Tanaka; Masami Tanaka; Itaru Toyoshima; Hirotoshi Sugino; Akio Yamakawa; Keiji Tanaka; Norio Niikawa; Fukumi Furukawa; Shigeo Murata; Katsumi Eguchi; Hiroaki Ida; Koh-Ichiro Yoshiura
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-18       Impact factor: 11.205

2.  Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease.

Authors:  Carl E I Janssen; Carlos D Rose; Gert De Hertogh; Tammy M Martin; Brigitte Bader Meunier; Rolando Cimaz; Miroslav Harjacek; Pierre Quartier; Rebecca Ten Cate; Caroline Thomee; Valeer J Desmet; Alain Fischer; Tania Roskams; Carine H Wouters
Journal:  J Allergy Clin Immunol       Date:  2012-04       Impact factor: 10.793

Review 3.  IL-10 and IL-10 receptor defects in humans.

Authors:  Erik-Oliver Glocker; Daniel Kotlarz; Christoph Klein; Neil Shah; Bodo Grimbacher
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

4.  Differentiation of Human Pluripotent Stem Cells into Colonic Organoids via Transient Activation of BMP Signaling.

Authors:  Jorge O Múnera; Nambirajan Sundaram; Scott A Rankin; David Hill; Carey Watson; Maxime Mahe; Jefferson E Vallance; Noah F Shroyer; Katie L Sinagoga; Adrian Zarzoso-Lacoste; Jonathan R Hudson; Jonathan C Howell; Praneet Chatuvedi; Jason R Spence; John M Shannon; Aaron M Zorn; Michael A Helmrath; James M Wells
Journal:  Cell Stem Cell       Date:  2019-05-02       Impact factor: 24.633

5.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.

Authors:  Nobuo Kanazawa; Ikuo Okafuji; Naotomo Kambe; Ryuta Nishikomori; Mami Nakata-Hizume; Sonoko Nagai; Akihiko Fuji; Takenosuke Yuasa; Akira Manki; Yoshihiko Sakurai; Mitsuru Nakajima; Hiroko Kobayashi; Ikuma Fujiwara; Hiroyuki Tsutsumi; Atsushi Utani; Chikako Nishigori; Toshio Heike; Tatsutoshi Nakahata; Yoshiki Miyachi
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

6.  The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model.

Authors:  Ivona Aksentijevich; Christopher D Putnam; Hal M Hoffman; Daniel L Kastner; Elaine F Remmers; James L Mueller; Julie Le; Richard D Kolodner; Zachary Moak; Michael Chuang; Frances Austin; Raphaela Goldbach-Mansky
Journal:  Arthritis Rheum       Date:  2007-04

7.  Trisomy correction in Down syndrome induced pluripotent stem cells.

Authors:  Li B Li; Kai-Hsin Chang; Pei-Rong Wang; Roli K Hirata; Thalia Papayannopoulou; David W Russell
Journal:  Cell Stem Cell       Date:  2012-10-18       Impact factor: 24.633

8.  Human iPSC-derived Down syndrome astrocytes display genome-wide perturbations in gene expression, an altered adhesion profile, and increased cellular dynamics.

Authors:  Blandine Ponroy Bally; W Todd Farmer; Emma V Jones; Selin Jessa; J Benjamin Kacerovsky; Alexandre Mayran; Huashan Peng; Julie L Lefebvre; Jacques Drouin; Arnold Hayer; Carl Ernst; Keith K Murai
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

9.  Down syndrome-related transient abnormal myelopoiesis is attributed to a specific erythro-megakaryocytic subpopulation with GATA1 mutation.

Authors:  Yoko Nishinaka-Arai; Akira Niwa; Shiori Matsuo; Yasuhiro Kazuki; Yuwna Yakura; Takehiko Hiroma; Tsutomu Toki; Tetsushi Sakuma; Takashi Yamamoto; Etsuro Ito; Mitsuo Oshimura; Tatsutoshi Nakahata; Megumu K Saito
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

10.  Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions.

Authors:  Masakatsu D Yanagimachi; Akira Niwa; Takayuki Tanaka; Fumiko Honda-Ozaki; Seiko Nishimoto; Yuuki Murata; Takahiro Yasumi; Jun Ito; Shota Tomida; Koichi Oshima; Isao Asaka; Hiroaki Goto; Toshio Heike; Tatsutoshi Nakahata; Megumu K Saito
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

View more
  1 in total

1.  Trapping of CDC42 C-terminal variants in the Golgi drives pyrin inflammasome hyperactivation.

Authors:  Masahiko Nishitani-Isa; Kojiro Mukai; Yoshitaka Honda; Hiroshi Nihira; Takayuki Tanaka; Hirofumi Shibata; Kumi Kodama; Eitaro Hiejima; Kazushi Izawa; Yuri Kawasaki; Mitsujiro Osawa; Yu Katata; Sachiko Onodera; Tatsuya Watanabe; Takashi Uchida; Shigeo Kure; Junko Takita; Osamu Ohara; Megumu K Saito; Ryuta Nishikomori; Tomohiko Taguchi; Yoji Sasahara; Takahiro Yasumi
Journal:  J Exp Med       Date:  2022-04-28       Impact factor: 17.579

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.